Related Experiment Video
Updated: May 22, 2026
10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Genetic association studies in diabetic nephropathy
Harvest F Gu1, Kerstin Brismar
1Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, SE-17176 Sweden. harvest.gu@ki.se
Current Diabetes Reviews
|May 17, 2012
Summary
Inherited factors strongly influence diabetic nephropathy development. Identifying susceptibility genes through genetic association studies is crucial for understanding pathophysiology and developing future therapies for this diabetes complication.
Area of Science:
- Genetics
- Nephrology
- Endocrinology
Background:
- Diabetic nephropathy shows familial aggregation across diverse ethnic groups, suggesting a significant genetic contribution.
- Understanding the genetic basis of diabetic nephropathy is key to elucidating its pathophysiology and developing targeted therapies.
Purpose of the Study:
- To review genetic polymorphisms associated with diabetic nephropathy.
- To summarize findings from genetic association studies in type 1 and type 2 diabetes.
- To discuss future directions in the genetic analysis of diabetic nephropathy.
Main Methods:
- Review of genetic polymorphisms.
- Summary of data from candidate gene population association studies.
- Summary of data from family-based association studies.
- Summary of data from genome-wide association studies.
Main Results:
- Genetic association studies have identified several polymorphisms linked to diabetic nephropathy susceptibility, resistance, and progression.
- Data from both type 1 and type 2 diabetes indicate a complex genetic architecture underlying the disease.
- The review synthesizes current knowledge on gene associations with diabetic nephropathy.
Conclusions:
- Inherited factors play a substantial role in the development and progression of diabetic nephropathy.
- Further genetic analyses are essential for a comprehensive understanding of this complex disease.
- Identifying key genes may pave the way for novel therapeutic strategies.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...